John Nuss - 13 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Scientific Officer
Signature
/s/ Christopher Krueger, As Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
13 Dec 2022
Net transactions value
-$1,201,078
Form type
4
Filing time
15 Dec 2022, 16:00:27 UTC
Previous filing
06 Dec 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $1,201,078 -35,000 -14% $34.32 223,696 13 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 35,000 shares sold in the price range of $34.14 to $34.54. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.